Abstract:Linear mixed models are traditionally used for jointly modeling (multivariate) longitudinal outcomes and event-time(s). However, when the outcomes are non-Gaussian a quantile regression model is more appropriate. In addition, in the presence of some time-varying covariates, it might be of interest to see how the effects of different covariates vary from one quantile level (of outcomes) to the other, and consequently how the event-time changes across different quantiles. For such analyses linear quantile mixed models can be used, and an efficient computational algorithm can be developed. We analyze a dataset from the Acute Lymphocytic Leukemia (ALL) maintenance study conducted by Tata Medical Center, Kolkata. In this study, the patients suffering from ALL were treated with two standard drugs (6MP and MTx) for the first two years, and three biomarkers (e.g. lymphocyte count, neutrophil count and platelet count) were longitudinally measured. After treatment the patients were followed nearly for the next three years, and the relapse-time (if any) for each patient was recorded. For this dataset we develop a Bayesian quantile joint model for the three longitudinal biomarkers and time-to-relapse. We consider an Asymmetric Laplace Distribution (ALD) for each outcome, and exploit the mixture representation of the ALD for developing a Gibbs sampler algorithm to estimate the regression coefficients. Our proposed model allows different quantile levels for different biomarkers, but still simultaneously estimates the regression coefficients corresponding to a particular quantile combination. We infer that a higher lymphocyte count accelerates the chance of a relapse while a higher neutrophil count and a higher platelet count (jointly) reduce it. Also, we infer that across (almost) all quantiles 6MP reduces the lymphocyte count, while MTx increases the neutrophil count. Simulation studies are performed to assess the effectiveness of the proposed approach.

Efficiently analyzing large patient registries with Bayesian joint models for longitudinal and time-to-event data

A joint model for (un)bounded longitudinal markers, competing risks, and recurrent events using patient registry data

Bayesian estimation for longitudinal data in a joint model with HPCs

Efficient Algorithms and Implementation of a Semiparametric Joint Model for Longitudinal and Competing Risks Data: With Applications to Massive Biobank Data

Joint Models for Time-to-Event Data and Longitudinal Biomarkers of High Dimension

Boosting joint models for longitudinal and time-to-event data

Bayesian blockwise inference for joint models of longitudinal and multistate data with application to longitudinal multimorbidity analysis

Integrating Latent Classes in the Bayesian Shared Parameter Joint Model of Longitudinal and Survival Outcomes

Jointly Modelling Longitudinal and Survival Data

Joint quantile regression of longitudinal continuous proportions and time-to-event data: Application in medication adherence and persistence

A two-stage approach for Bayesian joint models: reducing complexity while maintaining accuracy

Combining Dynamic Predictions From Joint Models for Longitudinal and Time-to-Event Data Using Bayesian Model Averaging

Joint modeling of zero-inflated longitudinal measurements and time-to-event outcomes with applications to dynamic prediction

Joint models for the longitudinal analysis of measurement scales in the presence of informative dropout

A Bayesian quantile joint modeling of multivariate longitudinal and time-to-event data

Fast and flexible inference for joint models of multivariate longitudinal and survival data using integrated nested Laplace approximations

A Flexible Joint Model for Multiple Longitudinal Biomarkers and A Time-to-Event Outcome: with Applications to Dynamic Prediction Using Highly Correlated Biomarkers

A Bayesian Approach to Modelling Longitudinal Data in Electronic Health Records

Joint models with multiple longitudinal outcomes and a time-to-event outcome: a corrected two-stage approach

A Bayesian joint model of multiple longitudinal and categorical outcomes with application to multiple myeloma using permutation-based variable importance